Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicenter Randomized Study on the Efficacy of Intravenous Iron Injection in Cancer Patients With Anemia

Next Previous
Trial Profile

Multicenter Randomized Study on the Efficacy of Intravenous Iron Injection in Cancer Patients With Anemia

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 15 Jun 2023 Primary endpoint has been met (Number of Hb responders defined as patients with increased Hb 1.0 g/dL from baseline, or reached to Hb 11.0 g/dL within 8-week observation period) , according to Results presented at the 28th Congress of the European Haematology Association
  • 15 Jun 2023 Status changed completed, according to Results presented at the 28th Congress of the European Haematology Association
  • 15 Jun 2023 Results presented at the 28th Congress of the European Haematology Association

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top